| Literature DB >> 27397598 |
Wenqing Ding1, Hong Cheng, Yinkun Yan, Xiaoyuan Zhao, Fangfang Chen, Guimin Huang, Dongqing Hou, Jie Mi.
Abstract
BACKGROUND: Serum lipid trends in children and adolescents are predictors of the future prevalence of cardiovascular disease in adults.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27397598 PMCID: PMC5121432 DOI: 10.2188/jea.JE20140252
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Characteristics of children and adolescents in Beijing, 2004 and 2014
| 2004 | 2014 | ||
| 1600 | 1649 | ||
| Mean (SE) age, years | 11.9 (0.1) | 11.4 (0.1) | <0.001 |
| Boys | 884 (55.3) | 895 (54.3) | 0.577 |
| Mean (SE) BMI, kg/m2 | 18.9 (0.9) | 19.4 (0.1) | <0.001a |
| Mean (SE) WC, cm | 65.2 (0.3) | 67.6 (0.3) | <0.001a |
| Overweightb | |||
| 6–9 years | 10.6 (7.3–14.0) | 14.6 (11.3–17.9) | 0.091 |
| 10–18 years | 9.7 (7.9–11.3) | 22.1 (19.4–24.9) | <0.001 |
| Obesityb | |||
| 6–9 years | 11.2 (7.9–14.5) | 19.4 (16.1–22.9) | 0.002 |
| 10–18 years | 7.6 (6.0–9.1) | 15.7 (13.3–18.3) | <0.001 |
| Abdominal obesityb | |||
| 6–9 years | 15.3 (11.8–18.9) | 24.7 (21.1–28.1) | <0.001 |
| 10–18 years | 13.5 (11.6–15.4) | 31.4 (28.4–34.4) | <0.001 |
| Types of obesity | |||
| Peripheral obesity | 0.3 (0.1) | 0.6 (0.2) | <0.001c |
| Abdominal obesity | 6.5 (0.6) | 15.2 (0.9) | |
| Mixed obesity | 7.4 (0.7) | 13.7 (0.9) |
BMI, body mass index; WC, waist circumference; SE, standard error of mean.
Comparisons were performed using chi-squares for sex and a two-sample t test for age.
aThe difference between 2004 and 2014 was tested using a general linear model adjusted for age and sex.
bReported as % (95% confidence interval).
cThe difference between 2004 and 2014 was tested using a logistic regression model adjusted for age and sex.
Mean serum lipid concentrations over time by sex and age among children and adolescents in Beijing, 2004–2014
| TC | TGa | HDL-C | Non-HDL-C | LDL-C | |||||||||||
| 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | ||||||
| 4.04 (0.02) | 4.25 (0.02) | <0.001 | 0.81 (0.01) | 0.88 (0.01) | <0.001 | 1.54 (0.01) | 1.47 (0.02) | <0.001 | 2.50 (0.02) | 2.77 (0.02) | <0.001 | 2.23 (0.01) | 2.35 (0.02) | <0.001 | |
| 4.00 (0.02) | 4.21 (0.02) | <0.001 | 0.78 (0.01) | 0.87 (0.01) | <0.001 | 1.53 (0.01) | 1.46 (0.01) | <0.001 | 2.47 (0.02) | 2.76 (0.02) | <0.001 | 2.23 (0.02) | 2.34 (0.02) | <0.001 | |
| Age, years | |||||||||||||||
| 6–9 | 4.20 (0.05) | 4.43 (0.04) | <0.001 | 0.76 (0.03) | 0.80 (0.02) | 0.907 | 1.63 (0.02) | 1.59 (0.02) | 0.331 | 2.55 (0.04) | 2.84 (0.03) | <0.001 | 2.36 (0.04) | 2.41 (0.03) | 0.329 |
| 10–18 | 3.94 (0.03) | 4.11 (0.03) | <0.001 | 0.79 (0.02) | 0.91 (0.02) | <0.001 | 1.49 (0.01) | 1.38 (0.01) | <0.001 | 2.45 (0.03) | 2.72 (0.03) | <0.001 | 2.18 (0.02) | 2.31 (0.03) | <0.001 |
| 4.08 (0.02) | 4.29 (0.03) | <0.001 | 0.85 (0.01) | 0.89 (0.01) | 0.038 | 1.55 (0.01) | 1.49 (0.01) | <0.001 | 2.52 (0.02) | 2.79 (0.02) | <0.001 | 2.25 (0.02) | 2.36 (0.02) | <0.001 | |
| Age, years | |||||||||||||||
| 6–9 | 4.11 (0.05) | 4.39 (0.04) | <0.001 | 0.81 (0.03) | 0.83 (0.03) | 0.266 | 1.56 (0.03) | 1.53 (0.02) | 0.684 | 2.55 (0.04) | 2.87 (0.04) | <0.001 | 2.33 (0.04) | 2.44 (0.04) | 0.080 |
| 10–18 | 4.06 (0.03) | 4.23 (0.03) | <0.001 | 0.87 (0.02) | 0.92 (0.02) | 0.006 | 1.55 (0.01) | 1.47 (0.01) | <0.001 | 2.52 (0.02) | 2.75 (0.03) | <0.001 | 2.23 (0.02) | 2.32 (0.03) | 0.004 |
HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. Non-HDL-C levels equal serum TC levels minus HDL-C. Data are presented as mean (SE). Linear trends in mean serum lipid concentrations were tested using a multivariate linear regression model adjusted for sex and age.
aThe distribution of TG is skewed. Data are presented as geometric means (SE).
Prevalence of abnormal serum lipids over time by sex and age among children and adolescents in Beijing, 2004–2014
| High TC | High TG | Low HDL-C | High non-HDL-C | |||||||||
| 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | |||||
| 4.9 (3.8–6.0) | 10.7 (9.2–12.2) | <0.001 | 9.1 (7.7–10.5) | 16.1 (14.3–17.9) | <0.001 | 6.0 (4.8–7.2) | 6.4 (5.2–7.6) | 0.503 | 2.8 (2.0–3.6) | 7.6 (6.3–8.9) | <0.001 | |
| 5.2 (3.7–6.7) | 10.7 (8.7–12.7) | <0.001 | 8.5 (6.6–10.4) | 15.4 (13.0–17.8) | <0.001 | 6.8 (5.1–8.5) | 8.5 (6.7–10.3) | 0.152 | 3.2 (2.0–4.4) | 7.0 (5.3–8.7) | 0.001 | |
| Age, years | ||||||||||||
| 6–9 | 6.3 (3.4–9.7) | 14.8 (10.4–18.9) | 0.006 | 13.5 (9.2–18.4) | 17.0 (12.9–21.5) | 0.134 | 1.4 (0.0–3.4) | 2.5 (0.9–4.4) | 0.408 | 2.9 (1.0–5.3) | 7.3 (4.4–10.4) | 0.054 |
| 10–18 | 4.7 (3.2–6.5) | 8.5 (6.2–10.9) | 0.003 | 6.9 (5.1–8.9) | 14.4 (11.8–27.3) | <0.001 | 8.5 (6.3–10.6) | 11.8 (9.2–14.6) | 0.257 | 3.3 (2.1–4.8) | 6.9 (5.0–9.0) | 0.003 |
| 4.7 (3.1–6.3) | 10.7 (8.5–12.9) | <0.001 | 10.2 (8.0–12.4) | 17.0 (14.3–19.7) | 0.001 | 5.0 (3.4–6.6) | 3.8 (2.4–5.2) | 0.317 | 2.3 (1.2–3.4) | 8.4 (6.4–10.4) | <0.001 | |
| Age, years | ||||||||||||
| 6–9 | 3.9 (1.3–7.1) | 13.5 (9.8–17.5) | 0.005 | 16.9 (11.7–23.4) | 22.5 (17.5–27.3) | 0.117 | 5.8 (2.6–7.9) | 2.9 (1.1–5.1) | 0.129 | 1.3 (0.0–3.2) | 9.1 (5.8–12.7) | 0.008 |
| 10–18 | 4.9 (3.1–6.9) | 9.2 (6.7–11.9) | 0.006 | 8.3 (6.2–10.7) | 13.8 (10.9–16.9) | 0.003 | 4.7 (3.1–6.5) | 4.4 (2.5–6.1) | 0.801 | 2.5 (1.3–4.0) | 7.9 (5.4–10.4) | 0.001 |
| High LDL-C | Hyperlipidemiaa | Dyslipidemiab | ||||||||||
| 2004 | 2014 | 2004 | 2014 | 2004 | 2014 | |||||||
| 3.4 (2.5–4.3) | 5.8 (4.7–6.9) | 0.002 | 13.3 (11.6–15.0) | 24.5 (22.4–26.6) | <0.001 | 18.8 (16.9–20.7) | 28.9 (26.7–31.3) | <0.001 | ||||
| 3.9 (2.6–5.2) | 5.3 (3.8–6.8) | 0.238 | 12.8 (10.6–15.0) | 24.4 (21.6–27.2) | <0.001 | 18.6 (16.0–21.2) | 30.0 (27.0–33.0) | <0.001 | ||||
| Age, years | ||||||||||||
| 6–9 | 3.9 (1.4–6.8) | 5.7 (3.2–8.5) | 0.470 | 18.4 (13.0–24.1) | 30.6 (25.6–35.6) | 0.001 | 19.3 (14.0–24.5) | 32.2 (27.1–37.5) | 0.001 | |||
| 10–18 | 3.8 (2.3–5.3) | 5.0 (3.3–6.9) | 0.202 | 10.9 (8.6–13.4) | 20.8 (17.7–24.1) | <0.001 | 18.3 (15.1–21.1) | 29.1 (25.3–32.9) | <0.001 | |||
| 2.8 (1.6–4.0) | 6.4 (4.7–8.1) | 0.002 | 14.0 (11.4–16.6) | 24.7 (21.6–27.8) | <0.001 | 17.3 (14.5–20.1) | 27.3 (24.1–30.5) | <0.001 | ||||
| Age, years | ||||||||||||
| 6–9 | 2.6 (0.6–5.2) | 6.9 (4.0–9.8) | 0.055 | 20.1 (14.3–27.3) | 32.0 (26.2–37.1) | 0.006 | 21.4 (15.6–28.6) | 33.8 (28.0–39.3) | 0.004 | |||
| 10–18 | 2.9 (1.6–4.3) | 6.1 (4.0–8.1) | 0.023 | 12.3 (9.6–15.2) | 20.5 (16.9–24.0) | <0.001 | 16.1 (13.2–19.3) | 23.6 (19.8–27.3) | 0.002 | |||
HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. Non-HDL-C levels equal serum TC minus HDL-C levels. Data are presented as prevalence (95% CI). Linear trends in the prevalence of abnormal serum lipids were tested using a multivariate logistic regression model adjusted for sex and age.
aHyperlipidemia: the presence of high TG or high TC levels.
bDyslipidemia: the presence of any one of the following four factors: high LDC-C, Low HDL-C, high TG or high TC levels.
Mean serum lipid concentrations among children and adolescents obesity extent and type
| TC | TGa | HDL-C | LDL-C | Non-HDL-C | |
| BMI | |||||
| Non-overweight | 4.25 (0.02) | 0.82 (0.01) | 1.53 (0.01) | 2.30 (0.02) | 2.72 (0.02) |
| Overweight | 4.21 (0.05) | 0.93 (0.04)* | 1.38 (0.02)* | 2.40 (0.04)* | 2.82 (0.04)* |
| Obesity | 4.33 (0.05) | 1.16 (0.04)*¥ | 1.33 (0.02)*¥ | 2.55 (0.04)*¥ | 3.01 (0.05)*¥ |
| | |||||
| WC | |||||
| Non-obese | 4.25 (0.02) | 0.81 (0.01) | 1.53 (0.01) | 2.30 (0.02) | 2.72 (0.02) |
| Abdominal obesity | 4.26 (0.03) | 1.07 (0.03) | 1.34 (0.01) | 2.48 (0.03) | 2.92 (0.03) |
| | |||||
| Types of obesity | |||||
| Non-obese | 4.24 (0.02) | 0.81 (0.01) | 1.53 (0.01) | 2.30 (0.02) | 2.72 (0.02) |
| Peripheral obesity | 4.45 (0.18) | 0.97 (0.18) | 1.52 (0.11) | 2.39 (0.15) | 2.93 (0.18) |
| Abdominal obesity | 4.21 (0.05) | 0.98 (0.04)Δ§ | 1.36 (0.02)Δ§ | 2.42 (0.04)Δ§ | 2.84 (0.04)Δ |
| Mixed obesity | 4.33 (0.05) | 1.17 (0.04)Δ#§ | 1.32 (0.02)Δ#§ | 2.56 (0.04)Δ#§ | 3.01 (0.05)Δ#§ |
| | <0.001 | <0.001 |
BMI, body mass index; WC, waist circumference; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. Non-HDL-C levels equal serum TC levels minus HDL-C levels. Data are presented as means (SEs).
aThe TG distribution is skewed. Data are presented as geometric means (SEs). Differences between mean serum lipid concentrations by obesity extents and types were tested using a general linear model with that adjusted for sex and age.
*P < 0.05 compared with non-overweight group.
¥P < 0.05 compared with overweight group.
ΔP < 0.05 compared with non-obese group.
#P < 0.05 compared with abdominal obesity group.
§P < 0.05 compared with peripheral obesity group.
Prevalence of abnormal levels of serum lipids among children and adolescents by obesity extent and type
| High TC | High TG | Low HDL-C | High LDL-C | High non-HDL-C | |
| BMI | |||||
| Non-overweight | 10.9 (9.1–12.7) | 11.4 (9.6–13.5) | 3.1 (2.1–4.1) | 4.8 (3.6–6.2) | 6.1 (4.7–7.7) |
| Overweight | 10.0 (6.3–13.7) | 18.5 (14.0–23.5)* | 12.3 (8.6–16.4)* | 6.2 (3.5–9.1) | 8.1 (4.9–11.2) |
| Obesity | 12.1 (8.3–16.7) | 37.2 (30.9–43.3)*¥ | 13.9 (9.3–18.3)*¥ | 9.9 (6.2–13.8)* | 14.8 (10.5–19.8)*¥ |
| | |||||
| WC | |||||
| Non-obese | 10.3 (8.6–12.0) | 10.9 (9.0–12.8) | 3.4 (2.4–4.5) | 4.4 (3.2–5.7) | 5.8 (4.5–7.3) |
| Abdominal obesity | 12.2 (9.3–15.4) | 29.6 (25.5–33.8) | 13.1 (9.8–16.1) | 9.1 (6.4–12.0) | 11.9 (9.0–15.1) |
| | |||||
| Types of obesity | |||||
| Non-obese | 10.3 (8.4–12.3) | 10.7 (8.9–12.7) | 3.3 (2.3–4.5) | 4.3 (3.2–5.6) | 5.7 (4.3–7.0) |
| Peripheral obesity | 11.1 (0.0–37.5) | 33.3 (0.0–66.7)Δ | 11.1 (0.0–33.3)Δ | 11.1 (0.0–37.5) | 22.2 (0.0–50.0) |
| Abdominal obesity | 12.2 (8.2–16.7) | 22.7 (17.7–28.2)Δ | 12.2 (8.1–16.9)Δ | 8.4 (5.0–12.2)Δ | 9.7 (6.1–13.4)Δ |
| Mixed obesity | 12.1 (7.9–16.7) | 37.4 (30.7–43.9)Δ# | 14.0 (9.7–18.9)Δ# | 9.8 (6.3–14.1)Δ | 14.5 (10.0–19.4)Δ |
| |
BMI, body mass index; WC, waist circumference. HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. Non-HDL-C levels equal serum TC levels minus HDL-C levels. Data are presented as prevalence (95% CI). Differences between mean serum lipid concentrations by obesity extent and type of were tested using a multivariate logistic regression model adjusted for sex and age.
*P < 0.05 compared with non-overweight group.
¥P < 0.05 compared with overweight group.
ΔP < 0.05 compared with non-obese group.
#P < 0.05 compared with abdominal obesity group.